Joseph-Leon Aumann - Concepedia

Author

Joseph-Leon Aumann

Also Known As

J. Aumann, Joseph-Leon Aumann, JosephLeon Aumann

Publications

318

Citations

H-Index

Concepts

All Affiliations

Joseph-Leon Aumann is an author at Boehringer Ingelheim (United States) specializing in pharmacotherapy, pulmonary disease, and atherosclerosis.

#	Concept	H-Index	Publications	Citations
1	Medicine	1	1	13
2	Pulmonary Disease	1	1	13
3	Pulmonary Medicine	1	1	13
4	Lung Inflammation	1	1	13
5	Lung Mechanics	1	1	13

Joseph-Leon Aumann

Publications

311

Citations

H-Index

Page 1

	Year	Citations
Treatment of asthma by the inhaled corticosteroid ciclesonide given either in the morning or evening D.S. Postma, C. Sevette, Yan Martinat, European Respiratory Journal	2001	130
Relationship between lung tissue and blood plasma concentrations of inhaled budesonide Jules M.M. van den Bosch, C. J. J. Westermann, Joseph-Leon Aumann, Biopharmaceutics & Drug Disposition	1993	90
Dual bronchodilation with tiotropium/olodaterol further reduces activity-related breathlessness<i>versus</i>tiotropium alone in COPD François Maltais, Joseph-Leon Aumann, Anne‐Marie Kirsten, European Respiratory Journal	2019	34
The 24 Hour Lung Function Time Profile of Olodaterol Once Daily Versus Placebo and Tiotropium in Patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease Joseph-Leon Aumann Journal of Pulmonary & Respiratory Medicine	2014	28
A randomised, double-blind, four-way, crossover trial comparing the 24-h FEV1 profile for once-daily versus twice-daily treatment with olodaterol, a novel long-acting β2-agonist, in patients with chronic obstructive pulmonary disease Guy Joos, Joseph-Leon Aumann, Carl Coeck, Respiratory Medicine	2015	16
The 24-h FEV1 time profile of olodaterol QD delivered via Respimat® in COPD: Results from two 6-week studies Peter Lange, Joseph-Leon Aumann, Eric Derom, Olodaterol QdGold 2-4 CopdPulmonary CareAdvanced Lung DiseaseLung Inflammation	2013	13

Page 1